Biomarker discovery & IP opportunities
Next generation targets & therapeutics
Information
The mass spectrometry based biomarker discovery and validation platform can be used for several pathologies. We focus on minimal invasive diagnostic applications for biomarker discovery so our preferred clinical samples are liquid biopsies (extracellular vesicles, urine, …). This focus gives us a unique capability and strength in terms of sample preparation as well as data analysis. Besides liquid samples, we can also use fresh and fixed tissue slides for biomarker discovery using a MALDI imaging approach.
Our developments have led to discoveries in biomarkers for
Kidney allograft rejection assessment
Lung cancer patient segmentation
and more
In this context we are open to collaborations and licensing to further our discoveries into marketable products.
Poster / URL
Presenting author:
Biomarker discovery & IP opportunities